Krystal Biotech, Inc. (KRYS)

347.00 +1.45 (+0.42%) USD  |  NASDAQ  |  Sep 11, 16:00
346.79 -0.21 (-0.06%) After-Hours: 20:00
More

Krystal Biotech EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for KRYS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical EPS Diluted (5 Year Growth) Data

View and export this data back to 2021. Start Trial.
Date Value
December 31, 2025 --
December 31, 2024 --
December 31, 2023 --
Date Value
December 31, 2022 --
December 31, 2021 --

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
TG Therapeutics, Inc. Upgrade
Cytokinetics, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Exelixis, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade